» Articles » PMID: 1303239

Presenile Dementia and Cerebral Haemorrhage Linked to a Mutation at Codon 692 of the Beta-amyloid Precursor Protein Gene

Overview
Journal Nat Genet
Specialty Genetics
Date 1992 Jun 1
PMID 1303239
Citations 169
Authors
Affiliations
Soon will be listed here.
Abstract

Several families with an early-onset form of familial Alzheimer's disease have been found to harbour mutations at a specific codon (717) of the gene for the beta-amyloid precursor protein (APP) on chromosome 21. We now report, a novel base mutation in the same exon of the APP gene which co-segregates in one family with presenile dementia and cerebral haemorrhage due to cerebral amyloid angiopathy. The mutation results in the substitution of alanine into glycine at codon 692. These results suggest that the clinically distinct entities, presenile dementia and cerebral amyloid angiopathy, can be caused by the same mutation in the APP gene.

Citing Articles

Production of Amyloid-β in the Aβ-Protein-Precursor Proteolytic Pathway Is Discontinued or Severely Suppressed in Alzheimer's Disease-Affected Neurons: Contesting the 'Obvious'.

Volloch V, Rits-Volloch S Genes (Basel). 2025; 16(1.

PMID: 39858593 PMC: 11764795. DOI: 10.3390/genes16010046.


Therapeutic implications of necroptosis activation in Alzheimer´s disease.

Carrazana E, Salvadores N Alzheimers Res Ther. 2024; 16(1):275.

PMID: 39726013 PMC: 11670415. DOI: 10.1186/s13195-024-01649-8.


Quintessential Synergy: Concurrent Transient Administration of Integrated Stress Response Inhibitors and BACE1 and/or BACE2 Activators as the Optimal Therapeutic Strategy for Alzheimer's Disease.

Volloch V, Rits-Volloch S Int J Mol Sci. 2024; 25(18).

PMID: 39337400 PMC: 11432332. DOI: 10.3390/ijms25189913.


The Fault in Our Astrocytes - cause or casualties of proteinopathies of ALS/FTD and other neurodegenerative diseases?.

Bustos L, Sattler R Front Mol Med. 2024; 3:1075805.

PMID: 39165755 PMC: 11334001. DOI: 10.3389/fmmed.2023.1075805.


Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer's Disease.

Petralla S, Panayotova M, Franchina E, Fricker G, Puris E Pharmaceutics. 2024; 16(7).

PMID: 39065645 PMC: 11279518. DOI: 10.3390/pharmaceutics16070948.